197 related articles for article (PubMed ID: 35813623)
1. Optimal Hormone Replacement Therapy in Hypothyroidism - A Model Predictive Control Approach.
Wolff TM; Dietrich JW; Müller MA
Front Endocrinol (Lausanne); 2022; 13():884018. PubMed ID: 35813623
[TBL] [Abstract][Full Text] [Related]
2. Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.
Wiersinga WM
Nat Rev Endocrinol; 2014 Mar; 10(3):164-74. PubMed ID: 24419358
[TBL] [Abstract][Full Text] [Related]
3. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.
Laurberg P; Andersen S; Bülow Pedersen I; Carlé A
Drugs Aging; 2005; 22(1):23-38. PubMed ID: 15663347
[TBL] [Abstract][Full Text] [Related]
4. Overt and subclinical hypothyroidism: who to treat and how.
Khandelwal D; Tandon N
Drugs; 2012 Jan; 72(1):17-33. PubMed ID: 22191793
[TBL] [Abstract][Full Text] [Related]
5. Liothyronine Improves Biochemical Control of Congenital Hypothyroidism in Patients with Central Resistance to Thyroid Hormone.
Paone L; Fleisch AF; Feldman HA; Brown RS; Wassner AJ
J Pediatr; 2016 Aug; 175():167-172.e1. PubMed ID: 27178621
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.
Escobar-Morreale HF; Botella-Carretero JI; Gómez-Bueno M; Galán JM; Barrios V; Sancho J
Ann Intern Med; 2005 Mar; 142(6):412-24. PubMed ID: 15767619
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine.
Escobar-Morreale HF; Botella-Carretero JI; Morreale de Escobar G
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):57-75. PubMed ID: 25617173
[TBL] [Abstract][Full Text] [Related]
8. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.
Clyde PW; Harari AE; Getka EJ; Shakir KM
JAMA; 2003 Dec; 290(22):2952-8. PubMed ID: 14665656
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone replacement therapy.
Wiersinga WM
Horm Res; 2001; 56 Suppl 1():74-81. PubMed ID: 11786691
[TBL] [Abstract][Full Text] [Related]
10. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters.
Jonklaas J; Burman KD
Thyroid; 2016 Jun; 26(6):770-8. PubMed ID: 27030088
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.
Jonklaas J; Bianco AC; Bauer AJ; Burman KD; Cappola AR; Celi FS; Cooper DS; Kim BW; Peeters RP; Rosenthal MS; Sawka AM;
Thyroid; 2014 Dec; 24(12):1670-751. PubMed ID: 25266247
[TBL] [Abstract][Full Text] [Related]
12. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.
Panicker V; Saravanan P; Vaidya B; Evans J; Hattersley AT; Frayling TM; Dayan CM
J Clin Endocrinol Metab; 2009 May; 94(5):1623-9. PubMed ID: 19190113
[TBL] [Abstract][Full Text] [Related]
13. Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis.
Eisenberg M; Samuels M; DiStefano JJ
Thyroid; 2008 Oct; 18(10):1071-85. PubMed ID: 18844475
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.
Celi FS; Zemskova M; Linderman JD; Smith S; Drinkard B; Sachdev V; Skarulis MC; Kozlosky M; Csako G; Costello R; Pucino F
J Clin Endocrinol Metab; 2011 Nov; 96(11):3466-74. PubMed ID: 21865366
[TBL] [Abstract][Full Text] [Related]
15. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
[TBL] [Abstract][Full Text] [Related]
16. Design of the Optimal Trial of Combination Therapy.
Cappola AR
Front Endocrinol (Lausanne); 2020; 11():168. PubMed ID: 32318021
[TBL] [Abstract][Full Text] [Related]
17. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.
Arici M; Oztas E; Yanar F; Aksakal N; Ozcinar B; Ozhan G
Endocr J; 2018 Mar; 65(3):317-323. PubMed ID: 29321381
[TBL] [Abstract][Full Text] [Related]
18. Simulation of post-thyroidectomy treatment alternatives for triiodothyronine or thyroxine replacement in pediatric thyroid cancer patients.
Ben-Shachar R; Eisenberg M; Huang SA; DiStefano JJ
Thyroid; 2012 Jun; 22(6):595-603. PubMed ID: 22578300
[TBL] [Abstract][Full Text] [Related]
19. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
Solter D; Solter M
Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
[TBL] [Abstract][Full Text] [Related]
20. [Combined l-thyroxine and l-triiodothyronine replacement therapy in congenital hypothyroidism].
Péter F; Muzsnai A
Orv Hetil; 2013 May; 154(19):738-44. PubMed ID: 23649638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
